Edap TMS SA (EDAP)
2.49
+0.04
(+1.63%)
USD |
NASDAQ |
Nov 21, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Edap TMS Debt to Equity Ratio: 0.089 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.089 |
June 30, 2024 | 0.0637 |
March 31, 2024 | 0.0819 |
December 31, 2023 | 0.1057 |
September 30, 2023 | 0.0673 |
June 30, 2023 | 0.0693 |
March 31, 2023 | 0.0678 |
December 31, 2022 | 0.0982 |
September 30, 2022 | 0.0708 |
June 30, 2022 | 0.1205 |
March 31, 2022 | 0.1144 |
December 31, 2021 | 0.1533 |
September 30, 2021 | 0.138 |
June 30, 2021 | 0.1382 |
March 31, 2021 | 0.0949 |
December 31, 2020 | 0.3167 |
September 30, 2020 | 0.1065 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.1803 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.2208 |
September 30, 2018 | 0.00 |
Date | Value |
---|---|
June 30, 2018 | 0.1428 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.1564 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.0684 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.0911 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.0742 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.2505 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.253 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.1707 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.2217 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.2733 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.2035 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.874 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.2764 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
0.3167
Maximum
Dec 2020
0.1038
Average
0.0965
Median
Debt to Equity Ratio Benchmarks
DBV Technologies SA | -- |
Cellectis SA | 0.3579 |
Genfit SA | 0.9462 |
Adaptimmune Therapeutics PLC | 0.6234 |
Akari Therapeutics PLC | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 88.28M |
Total Liabilities (Quarterly) | 40.66M |
Shareholders Equity (Quarterly) | 47.63M |
Current Ratio | 2.176 |
Net Debt Paydown Yield | 0.11% |